Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis

Irene Velasco, I Velasco, J Rueda, P Acién
Molecular human reproduction · 2006 · vol. 12(6) , pp. 377–381 · doi:10.1093/molehr/gal041 · PMID:16641167 · W2164757963
article OA: closed CC0 ⤵ 87 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study detected aromatase in endometriotic tissues and found that peritoneal fluid, IL-6, and TNFalpha stimulate its activity in endometriotic stromal cells and adipocytes.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one hand, to determine the presence of aromatase in eutopic and ectopic endometrium, healthy peritoneum, myometrium and leiomyomas from patients with (n = 61) and without endometriosis (n = 12) and, on the other hand, to determine the effect of peritoneal fluid (PF), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNFalpha) on aromatase activity from endometriotic stromal cells and subcutaneous adipocytes. After immunohistochemical analysis, aromatase expression was detected in the endometriotic tissue of 61% of patients, whereas the rest of the tissues, as well as those from disease-free women, were negative. Cell cultures were made to determine aromatase activity in endometriotic stromal cells and adipocytes. The addition of PF, TNFalpha and especially IL-6 (P < 0.05) stimulated the basal enzymatic activity observed in both cell types. Our findings confirm the presence of aromatase in endometriosis and probably the existence of a local estrogen production that may be stimulated by some factors such as cytokines present in the PF of these patients. Therefore, the use of aromatase inhibitors combined with immunomodulator agents could be a novel approach to be investigated in future clinical trials.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aromatase Endometriosis Endometrium Adipocytes Adipocytes Adipocytes Adipocytes Aromatase Ascitic Fluid Ascitic Fluid Cells, Cultured Dexamethasone Dexamethasone Endometriosis Endometriosis Endometrium Endometrium Female Humans Immunohistochemistry

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (33)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-18T06:15:08.409253+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0 · commercial use OK